Vimarsana
Biggest News Aggregation in the World

Page 30 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product (2) - Vimarsana News

Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product (2)

TAMPERE, Finland, March 30, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer in bioresorbable[1] orthopedic...

Insider information: FDA approves Bioretec's RemeOs™ trauma screw as the first bioresorbable metal implant in the U.S. market - Vimarsana News

Insider information: FDA approves Bioretec's RemeOs™ trauma screw as the first bioresorbable metal implant in the U.S. market

Bioretec Ltd                       Insider information       30... | March 30, 2023

Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product (1) - Vimarsana News

Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product (1)

TAMPERE, Finland, March 30, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer in bioresorbable[1] orthopedic...

Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product - Vimarsana News

Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product

/PRNewswire/ -- Bioretec Ltd, a pioneer in bioresorbable[1] orthopedic implants, has today announced receiving the market authorization of the U.S. Food and...

Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates - Vimarsana News

Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

Advanced preparations for potential commercial launch of BT-001 in U.S. in mid-2023 Reported positive topline results from exploratory trial for fatty liver disease Announced restructuring and... | March 30, 2023